Clinical Trial Update: Clinical Significance and Optimal Treatment of Community-onset Urinary Tract Infections Caused by Extended-spectrum β-lactamase and/or AmpC β-lactamase Producing Enterobacteriaceae

View source ↗

Summary

Clinical trial update examining the clinical significance and optimal treatment of community-onset urinary tract infections caused by ESBL/AmpC-producing Entero…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Urinary Tract Infection

Snippet

Sponsor: Taipei Veterans General Hospital, Taiwan | Conditions: Urinary Tract Infections | Status: UNKNOWN